Famciclovir patent dispute in Korea

Novaris's Korean subsidiary, Novartis Korea, has initiated legal action against Kyungdong Pharm, which is commercializing generic version of its antiviral agent, Famvir (famciclovir). The suit, which was filed to the Suwon District Court on August 5, alleges Kyungdong's potential infringement of Novartis's local process patent (Korean patent No. 66,974), which will last until 2015.

Famvir ta...